Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 1
2009 pubmed 58 citations

In vivo and in vitro structure-activity relationships and structural conformation of Kisspeptin-10-related peptides.

Gutiérrez-Pascual. Ester E; Leprince. Jérôme J; Martínez-Fuentes. Antonio J AJ; Ségalas-Milazzo. Isabelle I; Pineda. Rafael R; Roa. Juan J; Duran-Prado. Mario M; Guilhaudis. Laure L; Desperrois. Elia E; Lebreton. Aurélie A; Pinilla. Leonor L; Tonon. Marie-Christine MC; Malagón. María M MM; Vaudry. Hubert H; Tena-Sempere. Manuel M; Castaño. Justo P JP

Key Findings

  • Changing the amino acid at position 6 to alanine weakens but does not completely stop LH hormone release
  • Changing the amino acid at position 10 to alanine completely stops LH hormone release
  • The peptide’s helical shape is disrupted when position 10 is altered, indicating its structural importance

Practical Outcomes

  • For DIY biohackers, this study suggests that modifying kisspeptin‑10 is unlikely to boost fertility or performance and could render it ineffective. The findings highlight that the natural sequence is critical, so any self‑made analogs should be approached with caution and are not ready for practical use.

Summary

Scientists swapped out specific building blocks in the kisspeptin‑10 peptide and found that changes at two spots (positions 6 and 10) make the peptide far less able to trigger hormone release, showing those spots are essential for its activity.

Abstract

Kisspeptins, the natural ligands of the G protein-coupled receptor KISS1R, comprise a family of related peptides derived from the proteolytic processing of a common precursor encoded by the KISS1 gene. Among those, Kisspeptin-10 (Kp-10) contains the basic residues to retain full functional activity and exhibits higher receptor affinity and biopotency than longer forms of the peptide. Although kisspeptins were first characterized by their ability to inhibit tumor metastasis, recent studies have revealed that the KISS1/KISS1R system plays an essential role in the neuroendocrine control of the reproductive axis. In this context, development and functional analysis of Kp-10 analogs may help in the search for new agonists and antagonists as valuable tools to manipulate the KISS1/KISS1R system and hence fertility. We report herein functional and structural analyses of a series of Ala-substituted rat kp-10 analogs, involving [Ca(2+)](i) responses in rat kiss1r-transfected Chinese hamster ovary cells, dynamic luteinizing hormone (LH) responses in vivo, and NMR structural studies. In vitro assays revealed that Ala substitutions in positions 6 or 10 of kp-10 resulted in a significant increase in EC(50) values (>6.46 x 10(-6) M versus 1.54 to 2.6 x 10(-8) M for rat and human Kp-10, respectively) and a substantial decrease in the proportion of responsive cells coupled to a marked increase in the time required to reach maximal response. In vivo assays showed that Ala(6) substitution diminished and Ala(10) substitution eliminated LH secretory responses, whereas coadministration of each analog failed to affect the LH-releasing ability of kp-10. Molecular modeling under NMR restraints revealed that kp-10 exhibits a helicoidal structure between the Asn(4) and Tyr(10) residues, with mixed alpha- and 3(10)-helix characteristics. Ala(6) substitution induced limited destabilization of the helix around the position of the substitution. Ala(10) substitution was found to totally disrupt the helical structure in the C-terminal region of the molecule. Taken together, our results indicate that positions 6 and 10 are critical for kp-10 action at kiss1r and suggest that modifications in these positions could lead to the generation of new kisspeptin agonists and/or antagonists with altered functional and perhaps binding properties. Furthermore, they emphasize the importance of using combined, multidisciplinary approaches, including in vivo studies, to reliably evaluate structure function properties of novel kisspeptin analogs.

Study Information

Provider

pubmed

Year

2009

Date

2009-04-23T00:00:00.000Z

DOI

10.1124/mol.108.053751

Citations

58

References

45